|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1155400074 |
003 |
OCoLC |
005 |
20231120010453.0 |
006 |
m o d |
007 |
cr cnu|||||||| |
008 |
200527s2020 enka ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d OPELS
|d N$T
|d TXM
|d OCLCF
|d ORU
|d UCW
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1175761732
|
020 |
|
|
|a 9780128155868
|q (electronic bk.)
|
020 |
|
|
|a 0128155868
|q (electronic bk.)
|
020 |
|
|
|z 012815585X
|q (hardcover)
|
020 |
|
|
|z 9780128155851
|q (hardcover)
|
035 |
|
|
|a (OCoLC)1155400074
|z (OCoLC)1175761732
|
050 |
|
4 |
|a HD9999.B442
|
082 |
0 |
4 |
|a 338.476606
|2 23
|
245 |
0 |
0 |
|a Biotechnology entrepreneurship :
|b leading, managing and commercializing innovative technologies /
|c edited by Craig Shimasaki.
|
250 |
|
|
|a Second edition.
|
264 |
|
1 |
|a London, United Kingdom :
|b Academic Press,
|c [2020]
|
264 |
|
4 |
|c �2020
|
300 |
|
|
|a 1 online resource (xxxiii, 648 pages) :
|b color illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Online resource; title from digital title page (ScienceDirect, viewed May 3, 2021).
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g Section I.
|t Understanding biotechnology entrepreneurship
|t -- What is biotechnology entrepreneurship? /
|r Craig Shimasaki --
|t A biotechnology entrepreneur's legacy - Henri A. Termeer's story and his advice to entrepreneurs /
|r Henri A. Termeer --
|t A biotechnology entrepreneur's story: from start-up to international contract development and manufacturing organization /
|r Magda Marquet and Fra�nois Fer�r --
|t Seven characteristics of successful biotechnology leaders /
|r Lynn Johnson Langer --
|g Section II.
|t Overview of the biotechnology industry --
|t Unleashing the promise of biotechnology to help heal, fuel, and feed the world /
|r James C. Greenwood --
|t Five essential elements and regional influences required to grow and expand a biotechnology cluster or hub /
|r Craig Shimasaki --
|g Section III.
|t The human capital component --
|t Building, managing, and motivating great teams /
|r Arthur A. Boni, Gergana Todorova and Laurie R. Weingart --
|t Building human relationship networks /
|r Tom D. Walker --
|t Mentorship: Why you need a team of mentors to be successful /
|r Craig Shimasaki --
|g Section IV.
|t The innovative technology component --
|t Understanding biotechnology product sectors /
|r Craig Shimasaki --
|t Technology opportunities: evaluating the idea /
|r Craig Shimasaki --
|t Understanding biotechnology business models and managing risk /
|r Craig Shimasaki --
|t Directing your technology toward a market problem: What you need to know before using the business model canvas? /
|r Craig Shimasaki --
|g Section V.
|t The emerging biotechnology enterprise --
|t Company formation, ownership structure, and securities issues /
|r Craig C. Bradley --
|t Licensing the technology: Biotechnology commercialization strategies using university and federal labs /
|r Steven M. Ferguson and Uma S. Kaundinya --
|t Intellectual property protection strategies for biotechnology innovations /
|r Gerry J. Elman and Jay Z. Zhang --
|g Section VI.
|t The financial capital component --
|t Sources of capital and investor motivations /
|r Craig Shimasaki --
|t How investors really make decisions: What entrepreneurs need to know when raising money /
|r Konstantin S. Kostov --
|t Securing angel capital and understanding how angel networks operate /
|r Robert J. Calcaterra --
|t Understanding and securing venture capital: An entrepreneur's perspective /
|r Craig Shimasaki --
|t Financial ramifications of funding a biotechnology venture: What you need to know about valuation and term sheets /
|r Stephen M. Sammut --
|t Your business plan and presentation: Articulating your journey to commercialization /
|r Lowell W. Busenitz --
|t Investor presentations: What do you need in an investor pitch deck? /
|r Craig Shimasaki --
|g Section VII.
|t Biotechnology product development --
|t Therapeutic drug development and human clinical trials /
|r Donald R. Kirsch --
|t Integrating diagnostic products into the drug development workflow: Applications for companion diagnostics /
|r John F. Beeler --
|t The development and commercialization of medical devices /
|r Mark Byrne --
|t Commercialization and applications of agricultural biotechnology /
|r Neal Gutterson --
|t Artificial intelligence: Emerging applications in biotechnology and pharma /
|r David Sahner and David C. Spellmeyer --
|t Artificial intelligence in biotechnology: A framework for commercialization /
|r Robert E. Wanerman, Gail H. Javitt and Alaap B. Shah --
|t Regulatory approval and compliances for biotechnology products /
|r Norman W. Baylor and Donna-Bea Tillman --
|t The biomanufacturing of biotechnology products /
|r John Conner, Don Wuchterl, ... Chris Allen --
|t Biotechnology products and their customers: Developing a successful market strategy /
|r Craig Shimasaki --
|g Section VIII.
|t Biotechnology market development --
|t Biotechnology product coverage, coding, and reimbursement strategies /
|r Robert E. Wanerman and Susan Garfield --
|t Getting the word out: Public relations strategies to support biotechnology business goals /
|r Joan E. Kureczka --
|g Section IX.
|t The latter-stage biotechnology company --
|t Company growth stages and the value of corporate culture /
|r Craig Shimasaki --
|t Biotechnology business development: The art of the deal /
|r Jack M. Anthony, Philip Haworth and Gayle M. Mills --
|t Biotech-pharma collaboration-A strategic tool: Case study of Centocor /
|r Lara V. Marks --
|t The emergence and transformation of China in biotechnology /
|r Jimmy Zhimin Zhang --
|t Ethical considerations for biotechnology leaders /
|r Gladys B. White --
|t Diverse career opportunities in the biotechnology and life sciences industry /
|r Toby Freedman --
|t Common biotechnology entrepreneur mistakes and how to avoid them /
|r Craig Shimasaki --
|t Summary. /
|r Toby Freedman.
|
650 |
|
0 |
|a Biotechnology industries.
|
650 |
|
0 |
|a Entrepreneurship.
|
650 |
|
2 |
|a Entrepreneurship
|0 (DNLM)D016520
|
650 |
|
6 |
|a Bio-industries.
|0 (CaQQLa)201-0136258
|
650 |
|
6 |
|a Entrepreneuriat.
|0 (CaQQLa)201-0030347
|
650 |
|
7 |
|a entrepreneurs.
|2 aat
|0 (CStmoGRI)aat300025222
|
650 |
|
7 |
|a Biotechnology industries
|2 fast
|0 (OCoLC)fst00832791
|
650 |
|
7 |
|a Entrepreneurship
|2 fast
|0 (OCoLC)fst00912787
|
700 |
1 |
|
|a Shimasaki, Craig D.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|z 012815585X
|z 9780128155851
|w (OCoLC)1089577317
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128155851
|z Texto completo
|